CD274 and neoplasm: This fact implies that the efficacy of ICIs is essentially dependent on several modulating factors, including body composition, tumor burden, PD-L1 expression rate, and concordant medications that could exert immunomodulatory effects systemically and within the tumor microenvironment in addition to causing gut dysbiosis [4].